Cagent Vascular appoints Brian Walsh as CEO
Wayne, PA, May 7, 2024 (Business Wire) -- Brian Walsh, previously at Carl Zeiss, has been appointed as the new Chief Executive Officer at Cagent Vascular. His extensive experience in the medical device and healthcare industry positions him well to drive Cagent Vascular’s flagship product, Serranator.
Read full article here.
Comentarios